A detailed history of Tema Etfs LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Tema Etfs LLC holds 21,370 shares of IMCR stock, worth $768,251. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,370
Previous 22,206 3.76%
Holding current value
$768,251
Previous $697 Million 11.42%
% of portfolio
0.06%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$31.87 - $37.2 $26,643 - $31,099
-836 Reduced 3.76%
21,370 $776 Million
Q2 2025

Aug 13, 2025

BUY
$24.53 - $38.65 $166,264 - $261,969
6,778 Added 43.93%
22,206 $697 Million
Q1 2025

May 14, 2025

BUY
$28.21 - $33.0 $119,441 - $139,722
4,234 Added 37.82%
15,428 $458 Million
Q4 2024

Feb 14, 2025

BUY
$28.14 - $34.69 $314,999 - $388,319
11,194 New
11,194 $330 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.58B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.